We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech for less than cash value
An SI Board Since April 2002
Posts SubjectMarks Bans
564 118 0
Emcee:  RWReeves Type:  Unmoderated
At market bottoms in the land of Biotech stocks, a rather odd phenomena occurs. Some, indeed many, stocks which move so much on "story" and so little on actual financial analysis, sell for very, very little money. Now just cheap is not enough for us. Nay, we want value. Extreme value. We want candidates selling for less than cash in the bank, for less than liquidation value preferably

Old timers who remember the previous market bottoms will often share with wonder stories- (indeed fantasies of buying control of a stock for less than cash and selling off the assets) situations where there was some reasonable value of the technology, no impossibly large liability, and yet more cash per share than the market price. Sometimes these companies prove irresistable to other BTs or pharmas in mergers and takeovers. Sometimes the market "comes to it's senses". Other times they had a fatal flaw and could not recover from the spiral and the cash was burned to no avail.

Now this is another no-man's land where one should not wander carelessly. These represent very speculative investments by their nature and you MUST take responsibility for your own investment decisions and do your own analysis.

With that, I invite discussion and nominations of candidate biotechs selling currently for less than cash or liquidation value and will be putting some into a model portfolio.

Please don't use the forum for pumping a stock- and provide as much of a reasoned analysis or link to hard data as possible. This forum is un-moderated, you have only your credibility at risk by pumping one way or the other. Disclosure of interest is strongly encouraged.

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
564MEI Pharma (MEIP) announced on April 14 that it will receive $100 million in an Eph97-April 29
563FWP Forward Pharma: Check my math on this one but I think I calculated (Cash - tArea51-April 28
562PCTL is a company related to biotech, sanitation in hospitals, etc. If the figuGary Mohilner-March 3
561What do folks here think of SYBX? BladerunnerBladerunner17-February 17
560(P/C < 1.0) and (Week +10%) ADRO SURF VSTM VVUSJulius Wong-February 6
559Didn't know at the time of this discussion that RTB101 is also a pan-PI3K inscaram(o)uche-January 29
558(P/C < 1.0) and (Week +10%) ACOR ADRO CLBS CLDX CYCN LIFE MGEN MLNT NTRP NVJulius Wong-January 9
557Morgan Stanley discloses 8.8% torc position, joining Armistice Capital (9.6%) asscaram(o)uche-12/30/2019
556Thanks bmaz and Julius. BladerunnerBladerunner17-12/27/2019
555SYBX Synlogic’s first Synthetic Biotic™ medicines are designedJulius Wong-12/26/2019
554And here's my Microbiome summary sheet. If I'm missing any tickers, pleabmaz001-12/26/2019
553Here's a link to my SYBX workbook, blade. I've filtered the 'Followebmaz001-12/26/2019
552Anyone here follow SYBX? Opinions? BladerunnerBladerunner17-12/26/2019
551Hi Rick, I’ve met ADRO’s CEO, Steve Isaacs, a number of times and think he’s a gBulbaMan-12/19/2019
550Cool. Both of our contributions to the thread have PD-1 plus CD27 agonist projescaram(o)uche-12/19/2019
549ADRO is another cash rich biotech I’m considering for the 2020 SI Charity ContesBulbaMan112/19/2019
548resTORbio, Inc. ResTORbio stock plummets on late-stage drug faJulius Wong-12/18/2019
547Given recidivism, a market that would just keep on giving. Your parents should scaram(o)uche-12/18/2019
546I hadn't seen that abstract. Interesting. If it holds true in humans I'mbmaz001-12/18/2019
545Thanks! Brendan...... awesome effort, and I most appreciate the non-stop effoscaram(o)uche-12/18/2019
544Here's an August tweet of Brendan's biotech predictions that includes TObmaz001112/18/2019
543Here's a snapshot of my TORC cheat sheet. Twitter's @brendan_49 used to bmaz001112/18/2019
542Last reported shares outstanding, 36.3m. MC approximately $44m.scaram(o)uche-12/18/2019
541Anybody know and either like or hate TORC? @TraderTexMex often has a nice eye, scaram(o)uche-12/18/2019
540A 15:1 reverse split and the Cantor agreement seem to have kept them in about thscaram(o)uche-12/2/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):